DeepMed Research

INSTITUT CLAUDIUS REGAUD

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.claudiusregaud.fr

Clinical Trials

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Not Applicable

Not yet recruiting

Conditions: Urothelial Carcinoma
Renal Cancer
Prostate Adenocarcinoma
Adenocarcinoma of Endometrium
Cutaneous Melanoma
Soft Tissue Sarcoma (STS)
Nonseminomatous Germ Cell Tumor
Seminomatous Germ Cell Tumor
Upper Aerodigestive Tract Carcinoma
Cervical Carcinoma

First Posted Date: 2025-05-13

Last Posted Date: 2025-05-16

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 450

Registration Number: NCT06967961

Locations: 🇫🇷
Oncopole Claudius Regaud, IUCT-O, Toulouse, France

Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome

Not Applicable

Not yet recruiting

Conditions: Prostate Cancer

First Posted Date: 2025-04-08

Last Posted Date: 2025-04-08

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 80

Registration Number: NCT06917781

Locations: 🇫🇷
IUCT-O, Toulouse, France

Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer

Not Applicable

Not yet recruiting

Conditions: Metastatic Breast Cancer
Metastatic Prostate Cancer

First Posted Date: 2025-04-01

Last Posted Date: 2025-04-01

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 36

Registration Number: NCT06904625

Locations: 🇫🇷
IUCT-O, Toulouse, France

Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour

Not Applicable

Recruiting

Conditions: Intestinal Neuroendocrine Tumor

First Posted Date: 2025-03-14

Last Posted Date: 2025-04-10

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 150

Registration Number: NCT06876532

Locations: 🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷
Centre François Baclesse, Caen, France
🇫🇷
CHU de Lille, Lille, France

and more 5 locations

Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)

Not Applicable

Recruiting

Conditions: Solid Cancer
Haematological Malignancies

First Posted Date: 2025-01-28

Last Posted Date: 2025-05-20

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 33

Registration Number: NCT06797037

Locations: 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France

Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy

Not Applicable

Recruiting

Conditions: Ovarian Cancer

First Posted Date: 2024-09-19

Last Posted Date: 2025-05-01

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 130

Registration Number: NCT06588322

Locations: 🇫🇷
IUCT-O, Toulouse, France
🇫🇷
INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Angers, Angers, France
🇫🇷
Institut Bergonie, Bordeaux, France

and more 3 locations

Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention

Not Applicable

Not yet recruiting

Conditions: Brain Tumor, Pediatric

First Posted Date: 2024-09-19

Last Posted Date: 2025-03-25

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 130

Registration Number: NCT06599879

Locations: 🇫🇷
CHU Angers, Angers, France
🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷
Centre François Baclesse, Caen, France

and more 13 locations

Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study

Not Applicable

Recruiting

Conditions: Solid Tumours

Interventions: Other: Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP)

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-22

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 171

Registration Number: NCT06589414

Locations: 🇫🇷
CH Auch, Auch, France
🇫🇷
CHU Larrey, Toulouse, France
🇫🇷
CHU Rangueil, Toulouse, France

and more 1 locations

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Phase 2

Recruiting

Conditions: Squamous Cell Carcinoma of Head and Neck

Interventions: Drug: Pembrolizumab + Cisplatin/Carboplatin + 5-FU

First Posted Date: 2024-08-16

Last Posted Date: 2025-05-01

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 86

Registration Number: NCT06557889

Locations: 🇫🇷
IUCT-O, Toulouse, France
🇫🇷
CHU Poitiers, Poitiers, France
🇫🇷
Chu Bordeaux - Hopital Saint André, Bordeaux, France

and more 5 locations

Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners

Recruiting

Conditions: ORL Cancer

First Posted Date: 2024-07-24

Last Posted Date: 2025-05-14

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 45

Registration Number: NCT06517355

Locations: 🇫🇷
IUCT-O, Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy